Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients
Our observations provide novel insights into important metabolic human pathways and microbiome-derived metabolites to distinguish autoimmune pancreatitis from chronic pancreatitis. These findings reveal systemic metabolic responses and the identified metabolites may be developed into potential biomarkers for future diagnosis to distinguish between autoimmune pancreatitis and chronic pancreatitis.
Authors
- Vladyslav Dovhalyuk (ORCID: https://orcid.org/0000-0003-4170-7400)
- Matthias Löhr (ORCID: https://orcid.org/0000-0002-7647-198X)
- Miroslav Vujasinović (ORCID: https://orcid.org/0000-0002-6496-295X)
- Sara Nikolić (ORCID: https://orcid.org/0000-0003-3751-2619)
- Daniel Globisch (ORCID: https://orcid.org/0000-0002-4526-5788)
- Yang Fan (ORCID: https://orcid.org/0000-0002-9729-074X)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
- University Clinical Centre Maribor (SI)
Publication Details
- Journal
- United European Gastroenterology Journal
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1002/ueg2.70025
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Cancerfonden
- Vetenskapsrådet